Verition Fund Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-47,000
Closed -$295K 2159
2022
Q4
$295K Sell
47,000
-5,300
-10% -$37K ﹤0.01% 1515
2022
Q3
$360K Buy
52,300
+14,800
+39% +$103K ﹤0.01% 2106
2022
Q2
$313K Buy
+37,500
New +$524K 0.01% 1713
2022
Q1
Sell
-50,000
Closed -$1.38M 2724
2021
Q4
$1.38M Buy
+50,000
New +$1.34M 0.01% 1097
2021
Q3
Sell
-58,200
Closed -$1.71M 1912
2021
Q2
$1.71M Buy
+58,200
New +$1.76M 0.02% 591

Other funds holding BHC

Verition Fund Management's BHC Position: Q1 2026 in Review

Verition Fund Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 22,127 shares — an estimated $154K sold.

Verition Fund Management first reported a position in BHC in Q2 2013 and held it in 13 quarters. The position peaked at $3.79M in Q1 2022. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Verition Fund Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 22,127 Bausch Health shares in Q1 2026, an estimated $154K.
  • Verition Fund Management first reported a position in Bausch Health in Q2 2013 and held it in 13 quarters.
  • Verition Fund Management's Bausch Health position peaked at $3.79M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.